The move comes in a case involving an infant suffering from a rare condition, whose only potential cure is a one-time injection costing a staggering Rs 17.5 crore per unit, which can only be procured from overseas.
Related Posts
One in two people tested in India show high blood sugar levels: Report
Post Views: 8 The study also notes a gender gap,…
HLL pays Rs. 69.53 crores as dividend to health ministry for FY 2024-25
Post Views: 9 HLL Lifecare Limited has paid a record…
US regulators struggle to keep up with the fast-moving and complicated landscape of AI therapy apps
Post Views: 23 Federal agencies could consider restrictions on how…